HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maria Celeste M Ramirez Selected Research

Hyaline Fibromatosis Syndrome

4/2011Hyaline fibromatosis syndrome inducing mutations in the ectodomain of anthrax toxin receptor 2 can be rescued by proteasome inhibitors.
11/2006Systemic hyalinosis: a distinctive early childhood-onset disorder characterized by mutations in the anthrax toxin receptor 2 gene (ANTRX2).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maria Celeste M Ramirez Research Topics

Disease

2Hyaline Fibromatosis Syndrome
04/2011 - 11/2006
1Neoplasms (Cancer)
06/2013
1Myofibromatosis
06/2013
1Inborn Genetic Diseases (Disease, Hereditary)
04/2011
1Liver Diseases (Liver Disease)
02/2011
1Liver Cirrhosis (Hepatic Cirrhosis)
02/2011
1Fibrosis (Cirrhosis)
02/2011
1Wounds and Injuries (Trauma)
11/2006

Drug/Important Bio-Agent (IBA)

2anthrax toxin receptorsIBA
04/2011 - 11/2006
1Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
06/2013
1Proteasome InhibitorsIBA
04/2011
1Membrane Proteins (Integral Membrane Proteins)IBA
04/2011
1Messenger RNA (mRNA)IBA
02/2011
1Collagenases (Collagenase)FDA Link
02/2011
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
02/2011
1Matrix Metalloproteinases (MMPs)IBA
02/2011
1Collagen Type I (Type I Collagen)IBA
02/2011
1CollagenIBA
02/2011